home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Childhood Ritalin Reduces Adult Cocaine Reward

  December, 3 2001 8:50
your information resource in human molecular genetics
Exposing rats to stimulants during early life decreases the rewarding effects of cocaine in adulthood, reports a study in the January issue of Nature Neuroscience. The finding suggests that the administration of Ritalin to children with attention deficit hyperactivity disorder might affect their later responses to drugs of abuse.

Previous work had suggested that exposure to stimulants in adulthood increases sensitivity to drugs of abuse, raising the possibility that children treated with Ritalin might be at greater risk of drug abuse later in life. Susan Andersen and colleagues at Harvard Medical School provided evidence against this idea by injecting preadolescent rats with Ritalin, and then examining their sensitivity to cocaine during adulthood. The rats treated as juveniles with Ritalin failed to develop a preference for places associated with cocaine use, a common measure of the reward value of drugs of abuse, as adults. Rats given Ritalin in adulthood also showed less preference for places associated with cocaine than normal animals, but the change was not as great as in the younger group. The authors conclude that both groups showed reduced sensitivity to the rewarding effects of cocaine, and the younger group also showed increased sensitivity to the aversive effects of cocaine, suggesting that adult cocaine use might be less pleasant after childhood exposure to Ritalin.

Author contact:
Dr. Susan L. Andersen
Developmental Psychopharmacology Laboratory
McLean Hospital
Belmont, MA
Tel: +1 617 855 3211
E-mail andersen@mclean.org

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.